Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001930228 | SCV002133124 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003487812 | SCV004235382 | uncertain significance | not provided | 2023-06-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040371 | SCV004928471 | uncertain significance | Inborn genetic diseases | 2022-08-17 | criteria provided, single submitter | clinical testing | The c.1678C>A (p.P560T) alteration is located in exon 10 (coding exon 9) of the COL12A1 gene. This alteration results from a C to A substitution at nucleotide position 1678, causing the proline (P) at amino acid position 560 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |